This prospective cohort study aimed to use the hyperinsulinemic euglycemic clamp and other indicators to evaluate the effect of LRYGB and LSG on insulin sensitivity for T2DM patients with a BMI in 27.5–32.5 kg/m2. The gene discussed is INS; the disease is type 2 diabetes mellitus.